Schonfeld Strategic Advisors LLC
Position in LKFT — Lakefront Biotherapeutics NV
CIK 1665241
NEW YORK, NY
Position in LKFT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$977,258
-$2,190,847 QoQ
Shares Held
32,597
-36.2% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 78 holders
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. LKFT ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in LKFT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $977,258 | 32,597 | Shares | Sole | 2026-08-14 | |
| 2022-03-31 | $3,168,105 | 51,082 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,394,075 | 43,426 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $2,928,513 | 42,510 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $5,926,293 | 76,875 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,365,622 | 23,900 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,548,238 | 10,910 | Shares | Sole | 2020-11-19 | |
| No filing history on record for this holder in this stock. | ||||||